You are here: Industry Insights > china

News List

Amgen receives NMPA approval for Repatha in China biospectrumasia
January 29, 2019
Repatha is an innovative biologic medicine proven to effectively lower LDL-C
Merck and Tencent announce collaboration on intelligent digital healthcare services in China worldpharmanews
January 28, 2019
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services.
Flourishing WuXi Biologics in talks to make vaccines for scandal-hit China: report fiercepharma
January 24, 2019
WuXi Biologics has been surfing a surge of growth in biologic drugs, but the contract manufacturer isn't just interested in novel medications. It's also eyeing an older type of therapy: vaccines, which have come under special scrutiny in China lately.
Imported Drugs Approved through Priority Review in 2018 PharmaSources/zhulikou431
January 23, 2019
A memorandum of policies and imported drugs approved through priority review in 2018
Luye Pharma strengthens commitment to cardiovascular therapeutic field biospectrumasia
January 17, 2019
Luye Pharma grants AstraZeneca exclusives rights to promote Xuezhikang Capsules in mainland China.
Further scandal for China’s pharmaceutical industry europeanpharmaceuticalreview
January 15, 2019
Chinese police say they have opened an investigation into reports that at least 145 children received an expired polio vaccine…
NUI Galway opens stem cell research lab in China biospectrumasia
January 07, 2019
NUI Galway is expanding its international collaboration on high end medical research with a stem cell research centre in China jointly run with Hebei Medical University.
China’s Antengene raises $120m to boost drug development pharmaceutical-technology
January 03, 2019
Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.
Wuxi Biologics Begins Construction of Facility in Ireland contractpharma
December 27, 2018
WuXi Biologics has begun the construction of new biologics drug substance manufacturing facility in Ireland on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin, Dundalk, Co. Louth.
PPD Expands GMP Lab Testing Capabilities for Biologics contractpharma
December 27, 2018
Pharmaceutical Product Development, LLC (PPD) is adding gene and cell therapy analytical testing to its GMP (good manufacturing practices) laboratory in Athlone, Ireland, to support the pharmaceutical...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page